Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

Boehringer Ingelheim headquarters

NICE U-Turn on Boehringer oncology drug

England’s drug price watchdog now recommends Vargatef for lung cancer after price cut

- PMLiVE

Sanofi rare disease drug a breakthrough, says FDA

Regulator awarded the status to olipudase alfa for metabolic disorder

Recipharm appoints chief strategy officer

Jean-François Hilaire will take up the role with immediate effect

- PMLiVE

Patient engagement: the future for outcomes research and clinical trials?

There is growing momentum and recognition among researchers, regulatory agencies, policy makers and payers towards a more patient-centric approach to health outcomes research, including development and validation of Clinical Outcome...

Pharma deals in May 2015

The number of corporate acquisitions drops, finds Medius Deal Watch

- PMLiVE

IQWiG unimpressed with Tresiba for children

German cost watchdog says Novo’s insulin may in fact cause more harm in certain patients

- PMLiVE

FDA gives priority review for Keytruda in lung cancer

The regulator is expected to deliver a verdict by October 2 

- PMLiVE

Perrigo buys consumer health products from GSK

Several over-the-counter drug assets acquired at an undisclosed price

Roche Basel Switzerland

Roche maintains dominance as leading cancer drugmaker

But the firm’s growth is stalling as pricing pressures hit sales

- PMLiVE

Turing names Eliseo Salinas as head of R&D

He joins from Relmada Therapeutics where he was president

- PMLiVE

Bayer renews contract with Ashfield Meetings & Events

Partnership have been working together since 2012

- PMLiVE

Amgen and Merck to expand cancer collaboration

Firms to test Keytruda in combination for cancers inside the head and neck

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links